Infantile spasms: Knowledge, attitude, and practice of pediatricians in Turkey

Deniz Yılmaz1, Özlem Yayıcı Köken1, Esra Gürkaş1

  • 1Department of Pediatric Neurology, Children's' Hospital, Ankara City Hospital, Ankara, Turkey.

Epilepsy & Behavior : E&B
|December 5, 2021
PubMed

Insights

Pediatricians show varying knowledge of Infantile Spasms Syndrome (ISS), a severe epilepsy. Enhancing medical education and public awareness is crucial for early diagnosis and treatment of this condition.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Medical Education

Background:

  • Infantile Spasms Syndrome (ISS) includes West Syndrome (WS) and other infantile epileptic spasms.
  • WS is characterized by epileptic spasms, developmental stagnation/regression, and hypsarrhythmia.

Purpose of the Study:

  • To assess Turkish pediatricians' and residents' knowledge, attitude, and practice (KAP) regarding ISS.
  • To identify gaps in understanding and inform educational strategies for ISS diagnosis.

Main Methods:

  • Cross-sectional study utilizing a 45-question KAP survey.
  • Survey administered to pediatricians and residents across Turkey.

Main Results:

  • Most participants (91.4%) recognized ISS as epilepsy.
  • Structural abnormalities and genetic disorders were the most cited etiologies.
  • Infantile colic and GERD were common misdiagnoses; EEG and referral to pediatric neurologists were widely agreed upon.
  • Steroids were considered first-line treatment by half.

Conclusions:

  • Medical education is vital for improving ISS diagnostic awareness.
  • Public awareness campaigns combined with education can facilitate rapid diagnosis.
  • Tailored educational strategies are needed, considering socio-cultural contexts.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
687
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K